CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 207 enrolled
Drug / intervention
Troacar site infiltration +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06429163
NCT06429163N/ACompleted

Impact of Pre-incisional Wound Infiltration and Hypogastric Plexus Block Using Ropivacaine on Postoperative Pain Following Laparoscopic Myomectomy: A Single-Center, Prospective, Randomized, Placebo-Controlled, Double-Blind Study

Saint Petersburg State University, Russia·interventional·Posted May 24, 2024·Updated Jan 6, 2026

In Brief

A clinical study evaluating Troacar site infiltration and Superior hypogastric plexus block for Fibroid Uterus and Pain, Postoperative. Completed, enrolled 207 participants across 1 site.

Detailed Summary

The purpose of this study is to assess an impact of laparoscopic superior hypogastric plexus (SHP) block combined with preemptive troacar site infiltration on postoperative pain intensity following laparoscopic myomectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMay 24, 2024
Enrollment StartMay 14, 2024
Primary CompletionJan 26, 2025
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.1 years ago

Interventions

Troacar site infiltrationprocedure

Infiltration of the anterior abdominal wall is performed with placebo or 0.2% ropivacaine diluted with physiological saline on a syringe in the volume of 20 ml - 5 ml for each incision. The drug is injected with a 22-gauge needle at a 90-degree angle.

Superior hypogastric plexus blockprocedure

At the beginning of the operation the camera is used to visualise the area of the promontorium. Next, a 1 mm laparoscopic puncture needle is inserted through a trocar in the suprapubic region and plunged into the upper part of the formed dome to a depth of no more than 1 cm. After positioning the needle retroperitoneally, an aspiration test is performed to prevent intravascular injection. Then, 20 ml of placebo or 0.2% ropivacaine diluted with physiological saline is slowly injected. At the end of the procedure, the retroperitoneal space swollen by the local anaesthetic is visualised in the promontorium.